Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Lake Street says Tandem pact with Abbott, coverage news both 'very positive' » 09:14
07/01/20
07/01
09:14
07/01/20
09:14
TNDM

TNDM

/

+

, ABT

Abbott

$91.53 /

+2.59 (+2.91%)

, UNH

UnitedHealth

$294.79 /

+5.49 (+1.90%)

Lake Street analyst…

Lake Street analyst Brooks O'Neil affirms his Buy rating and $125 price target on Tandem Diabetes (TNDM) shares following two positive developments. First, Tandem and Abbott (ABT) announced they have finalized an agreement to develop and commercialize integrated diabetes solutions, although his "best guess" is it will not result in a product on the market with an integrated offering for at least a year. Second, he notes indications that UnitedHealthcare (UNH) will cover Tandem's t:slim X2 insulin pumps on an in-network basis as of July 1. While neither of these agreements will affect Tandem's results in the June quarter, O'Neil calls both "very positive."

ShowHide Related Items >><<
UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

TNDM TNDM
/

+

ABT Abbott
$91.53 /

+2.59 (+2.91%)

TNDM TNDM
/

+

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
ABT Abbott
$91.53 /

+2.59 (+2.91%)

06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
06/01/20
Fly Intel: Top five analyst downgrades
UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

TNDM TNDM
/

+

ABT Abbott
$91.53 /

+2.59 (+2.91%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

ABT Abbott
$91.53 /

+2.59 (+2.91%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

TNDM TNDM
/

+

ABT Abbott
$91.53 /

+2.59 (+2.91%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

ABT Abbott
$91.53 /

+2.59 (+2.91%)

Tuesday
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 17:29
06/30/20
06/30
17:29
06/30/20
17:29
MU

Micron

$51.50 /

+2.38 (+4.85%)

, WFC

Wells Fargo

$25.57 /

-0.13 (-0.51%)

, RDS.A

Royal Dutch Shell

$32.70 /

-0.73 (-2.18%)

, RDS.B

Royal Dutch Shell

$30.54 /

-0.785 (-2.51%)

, LULU

Lululemon

$311.96 /

+18.51 (+6.31%)

, UBER

Uber

$31.07 /

+1.435 (+4.84%)

, EADSY

Airbus

$0.00 /

+ (+0.00%)

, TNDM

TNDM

/

+

, UNH

UnitedHealth

$294.79 /

+5.49 (+1.90%)

, AYI

Acuity Brands

$95.47 /

+6.24 (+6.99%)

, LQDA

Liquidia Technologies

$8.36 /

-2.32 (-21.72%)

, INO

Inovio

$26.88 /

-4.83 (-15.23%)

Stocks gained to close…

Open Full Text

ShowHide Related Items >><<
WFC Wells Fargo
$25.57 /

-0.13 (-0.51%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

UBER Uber
$31.07 /

+1.435 (+4.84%)

TNDM TNDM
/

+

RDS.B Royal Dutch Shell
$30.54 /

-0.785 (-2.51%)

RDS.A Royal Dutch Shell
$32.70 /

-0.73 (-2.18%)

MU Micron
$51.50 /

+2.38 (+4.85%)

LULU Lululemon
$311.96 /

+18.51 (+6.31%)

LQDA Liquidia Technologies
$8.36 /

-2.32 (-21.72%)

INO Inovio
$26.88 /

-4.83 (-15.23%)

EADSY Airbus
$0.00 /

+ (+0.00%)

AYI Acuity Brands
$95.47 /

+6.24 (+6.99%)

MU Micron
$51.50 /

+2.38 (+4.85%)

06/30/20 RBC Capital
Micron price target raised to $60 from $55 at RBC Capital
06/30/20 Morgan Stanley
Morgan Stanley would add to Micron positions on weakness in coming 'rough patch'
06/30/20 Raymond James
Micron price target raised to $65 from $60 at Raymond James
06/30/20 Mizuho
Micron price target raised to $63 from $60 at Mizuho
WFC Wells Fargo
$25.57 /

-0.13 (-0.51%)

06/30/20 JPMorgan
Wells Fargo needs to cut dividend 'much more' than 25%, says JPMorgan
06/30/20 RBC Capital
Wells Fargo price target lowered to $29 from $35 at RBC Capital
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/11/20 JPMorgan
Wells Fargo dividend very likely to be cut, says JPMorgan
RDS.A Royal Dutch Shell
$32.70 /

-0.73 (-2.18%)

06/15/20 UBS
Royal Dutch Shell price target raised to 1,750 GBp from 1,650 GBp at UBS
05/13/20 Redburn
Royal Dutch Shell upgraded to Neutral from Sell at Redburn
05/04/20 UBS
Royal Dutch Shell price target lowered to 1,700 GBp from 1,800 GBp at UBS
05/01/20 Citi
Citi cuts Royal Dutch Shell price target 11% to GBp 1180
RDS.B Royal Dutch Shell
$30.54 /

-0.785 (-2.51%)

06/04/20 RBC Capital
Royal Dutch Shell price target raised to 2,000 GBp from 1,800 GBp at RBC Capital
05/04/20 UBS
Royal Dutch Shell price target lowered to 1,700 GBp from 1,800 GBp at UBS
04/21/20 JPMorgan
Royal Dutch Shell price target lowered to 1,650 GBp from 1,750 GBp at JPMorgan
LULU Lululemon
$311.96 /

+18.51 (+6.31%)

06/30/20 Morgan Stanley
Lululemon boosted competitive advantage with Mirror deal, says Morgan Stanley
06/30/20 MKM Partners
Lululemon's Mirror deal 'highly attractive and synergistic', says MKM Partners
06/30/20 Roth Capital
Roth boosts Peloton target to $66, says buy Mirror acquisition selloff
06/30/20 Piper Sandler
Piper Sandler favors Lululemon acquisition of Mirror
UBER Uber
$31.07 /

+1.435 (+4.84%)

07/01/20 BTIG
Uber consensus likely aggressive, says BTIG
06/30/20 SunTrust
Uber shouldn't face regulatory issues if it buys Postmates, says Suntrust
06/25/20 Deutsche Bank
Yandex interest in Uber's minority stake modest positive, says Deutsche Bank
06/16/20 JPMorgan
JPMorgan continues to prefer Facebook, Snap in online advertising
EADSY Airbus
$0.00 /

+ (+0.00%)

06/26/20 Bernstein
Airbus downgraded to Market Perform from Outperform at Bernstein
06/11/20 Credit Suisse
Hexcel price target raised to $52 from $34 at Credit Suisse
06/08/20 Goldman Sachs
Boeing price target raised to $238 from $209 at Goldman Sachs
05/07/20 Barclays
Airbus price target lowered to EUR 68 from EUR 69 at Barclays
TNDM TNDM
/

+

06/30/20 Stifel
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel
06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

07/01/20 SVB Leerink
UnitedHealth reinstated with an Outperform at SVB Leerink
AYI Acuity Brands
$95.47 /

+6.24 (+6.99%)

07/01/20 Credit Suisse
Acuity Brands price target raised to $115 from $109 at Credit Suisse
06/16/20
Fly Intel: Top five analyst downgrades
06/15/20 Goldman Sachs
Acuity Brands downgraded to Sell from Neutral at Goldman Sachs
06/09/20 JMP Securities
Acuity Brands downgraded to Market Perform from Outperform at JMP Securities
LQDA Liquidia Technologies
$8.36 /

-2.32 (-21.72%)

04/08/20 Wedbush
Liquidia Technologies price target raised to $41 from $37 at Wedbush
01/27/20 Wedbush
Liquidia NDA acceptance reduces regulatory risk, says Wedbush
12/26/19 Wedbush
Liquidia Technologies price target lowered to $37 from $50 at Wedbush
INO Inovio
$26.88 /

-4.83 (-15.23%)

07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
06/30/20 RBC Capital
RBC keeps Sector Perform on Inovio following 'positive' COVID-19 vaccine update
WFC Wells Fargo
$25.57 /

-0.13 (-0.51%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

UBER Uber
$31.07 /

+1.435 (+4.84%)

TNDM TNDM
/

+

RDS.A Royal Dutch Shell
$32.70 /

-0.73 (-2.18%)

MU Micron
$51.50 /

+2.38 (+4.85%)

LULU Lululemon
$311.96 /

+18.51 (+6.31%)

LQDA Liquidia Technologies
$8.36 /

-2.32 (-21.72%)

INO Inovio
$26.88 /

-4.83 (-15.23%)

EADSY Airbus
$0.00 /

+ (+0.00%)

AYI Acuity Brands
$95.47 /

+6.24 (+6.99%)

  • 30
    Jun
  • 11
    Feb
  • 24
    Dec
  • 13
    Dec
  • 07
    Nov
  • 06
    Nov
WFC Wells Fargo
$25.57 /

-0.13 (-0.51%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

UBER Uber
$31.07 /

+1.435 (+4.84%)

RDS.B Royal Dutch Shell
$30.54 /

-0.785 (-2.51%)

RDS.A Royal Dutch Shell
$32.70 /

-0.73 (-2.18%)

MU Micron
$51.50 /

+2.38 (+4.85%)

LULU Lululemon
$311.96 /

+18.51 (+6.31%)

INO Inovio
$26.88 /

-4.83 (-15.23%)

EADSY Airbus
$0.00 /

+ (+0.00%)

WFC Wells Fargo
$25.57 /

-0.13 (-0.51%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

UBER Uber
$31.07 /

+1.435 (+4.84%)

TNDM TNDM
/

+

RDS.B Royal Dutch Shell
$30.54 /

-0.785 (-2.51%)

RDS.A Royal Dutch Shell
$32.70 /

-0.73 (-2.18%)

MU Micron
$51.50 /

+2.38 (+4.85%)

LULU Lululemon
$311.96 /

+18.51 (+6.31%)

LQDA Liquidia Technologies
$8.36 /

-2.32 (-21.72%)

INO Inovio
$26.88 /

-4.83 (-15.23%)

EADSY Airbus
$0.00 /

+ (+0.00%)

AYI Acuity Brands
$95.47 /

+6.24 (+6.99%)

WFC Wells Fargo
$25.57 /

-0.13 (-0.51%)

UNH UnitedHealth
$294.79 /

+5.49 (+1.90%)

UBER Uber
$31.07 /

+1.435 (+4.84%)

MU Micron
$51.50 /

+2.38 (+4.85%)

LULU Lululemon
$311.96 /

+18.51 (+6.31%)

LQDA Liquidia Technologies
$8.36 /

-2.32 (-21.72%)

INO Inovio
$26.88 /

-4.83 (-15.23%)

Recommendations
Tandem Diabetes target raised to $80 after UnitedHealth coverage news at Stifel » 15:43
06/30/20
06/30
15:43
06/30/20
15:43
TNDM

TNDM

/

+

, MDT

Medtronic

$91.20 /

+0.98 (+1.09%)

, UNH

UnitedHealth

$292.91 /

+3.61 (+1.25%)

Stifel analyst Mathew…

Stifel analyst Mathew Blackman raised the firm's price target on Tandem Diabetes (TNDM) to $80 from $75 following news that UnitedHealth (UNH) will now cover the company's t:slim pump for all in-network patients. While certainly a "win" for Tandem, it is not unexpected and he sees "a couple of caveats" in the new coverage decision, Blackman tells investors. Specifically, Tandem pumps will require "cumbersome" pre-authorization steps, while Medtronic's (MDT) new agreement with the insurer eliminates these "insurance verification headwinds," the analyst said. Also, Medtronic has layered in price/volume discounting if UnitedHealth maintains unspecified volumes, which suggests that Medtroic may be protecting its business better than the market reaction today might imply, said Blackman. He keeps a Hold rating on Tandem shares.

ShowHide Related Items >><<
UNH UnitedHealth
$292.91 /

+3.61 (+1.25%)

TNDM TNDM
/

+

MDT Medtronic
$91.20 /

+0.98 (+1.09%)

TNDM TNDM
/

+

06/30/20 Oppenheimer
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer
06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
06/18/20 Raymond James
Tandem Diabetes price target raised to $95 from $88 at Raymond James
MDT Medtronic
$91.20 /

+0.98 (+1.09%)

06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
UNH UnitedHealth
$292.91 /

+3.61 (+1.25%)

06/05/20 Goldman Sachs
UnitedHealth initiated with a Buy at Goldman Sachs
06/02/20 Stephens
UnitedHealth price target raised to $325 from $310 at Stephens
UNH UnitedHealth
$292.91 /

+3.61 (+1.25%)

TNDM TNDM
/

+

MDT Medtronic
$91.20 /

+0.98 (+1.09%)

UNH UnitedHealth
$292.91 /

+3.61 (+1.25%)

MDT Medtronic
$91.20 /

+0.98 (+1.09%)

UNH UnitedHealth
$292.91 /

+3.61 (+1.25%)

TNDM TNDM
/

+

MDT Medtronic
$91.20 /

+0.98 (+1.09%)

UNH UnitedHealth
$292.91 /

+3.61 (+1.25%)

MDT Medtronic
$91.20 /

+0.98 (+1.09%)

Recommendations
UnitedHealth to start covering Tandem insulin pump, says Oppenheimer » 13:03
06/30/20
06/30
13:03
06/30/20
13:03
TNDM

TNDM

/

+

, UNH

UnitedHealth

$289.80 /

+0.5 (+0.17%)

, MDT

Medtronic

$90.50 /

+0.28 (+0.31%)

Effective July 1,…

Effective July 1, UnitedHealth (UNH) and Medtronic (MDT) will enter into a new four-year agreement whereby Medtronic will no longer be the preferred provider of insulin pumps for United members and United will start covering Tandem Diabetes' (TNDM) t:slim X2 pump on an in-network basis, Oppenheimer analyst Steven Lichtman tells investors in a research note. The news is a "nice incremental positive" for Tandem as the company has been essentially shut out of UnitedHealth for about four years, says the analyst. Lichtman believes the approval of Tandem's Control-IQ and the publication of the data were drivers of the UnitedHealth's move to add the device. He believes the news offers potential upside to estimates and keeps an Outperform rating on Tandem Diabetes. The stock in afternoon trading is up 7% to $94.33.

ShowHide Related Items >><<
UNH UnitedHealth
$289.80 /

+0.5 (+0.17%)

TNDM TNDM
/

+

MDT Medtronic
$90.50 /

+0.28 (+0.31%)

TNDM TNDM
/

+

06/30/20 Piper Sandler
United Health coverage a 'clear positive' for Tandem, says Piper Sandler
06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
06/18/20 Raymond James
Tandem Diabetes price target raised to $95 from $88 at Raymond James
06/18/20 Lake Street
Tandem Diabetes price target raised to $125 from $100 at Lake Street
UNH UnitedHealth
$289.80 /

+0.5 (+0.17%)

06/05/20 Goldman Sachs
UnitedHealth initiated with a Buy at Goldman Sachs
06/02/20 Stephens
UnitedHealth price target raised to $325 from $310 at Stephens
06/01/20 Piper Sandler
Kentucky contract positive for Molina, negative for Anthem, says Piper Sandler
MDT Medtronic
$90.50 /

+0.28 (+0.31%)

06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
UNH UnitedHealth
$289.80 /

+0.5 (+0.17%)

TNDM TNDM
/

+

MDT Medtronic
$90.50 /

+0.28 (+0.31%)

UNH UnitedHealth
$289.80 /

+0.5 (+0.17%)

MDT Medtronic
$90.50 /

+0.28 (+0.31%)

UNH UnitedHealth
$289.80 /

+0.5 (+0.17%)

TNDM TNDM
/

+

MDT Medtronic
$90.50 /

+0.28 (+0.31%)

UNH UnitedHealth
$289.80 /

+0.5 (+0.17%)

MDT Medtronic
$90.50 /

+0.28 (+0.31%)

Recommendations
United Health coverage a 'clear positive' for Tandem, says Piper Sandler » 12:11
06/30/20
06/30
12:11
06/30/20
12:11
TNDM

TNDM

/

+

, UNH

UnitedHealth

$290.00 /

+0.7 (+0.24%)

, MDT

Medtronic

$90.60 /

+0.38 (+0.42%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien reported that Medtronic's (MDT) investor relations team stated as part of an update on its insulin pump and CGM arrangement with United Health (UNH) that the insurer will be covering Tandem Diabetes' (TNDM) t:slim pump in-network going forward. The analyst, who noted that Medtronic is still the preferred vendor and that the updated arrangement has volume minimums associated with it, calls this news a "clear positive" for Tandem as he argues that easier access to its pumps will likely lead to significantly more uptake from this group of patients. O'Brien, who sees this coverage news as another revenue tailwind for Tandem in the coming years, keeps an Overweight rating on the stock.

ShowHide Related Items >><<
UNH UnitedHealth
$290.00 /

+0.7 (+0.24%)

TNDM TNDM
/

+

MDT Medtronic
$90.60 /

+0.38 (+0.42%)

TNDM TNDM
/

+

06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
06/18/20 Raymond James
Tandem Diabetes price target raised to $95 from $88 at Raymond James
06/18/20 Lake Street
Tandem Diabetes price target raised to $125 from $100 at Lake Street
06/17/20 Piper Sandler
Tandem Diabetes Q2 tracking better than expected, says Piper Sandler
UNH UnitedHealth
$290.00 /

+0.7 (+0.24%)

06/05/20 Goldman Sachs
UnitedHealth initiated with a Buy at Goldman Sachs
06/02/20 Stephens
UnitedHealth price target raised to $325 from $310 at Stephens
06/01/20 Piper Sandler
Kentucky contract positive for Molina, negative for Anthem, says Piper Sandler
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
MDT Medtronic
$90.60 /

+0.38 (+0.42%)

06/18/20 Argus
Medtronic has strong growth opportunities, says Argus
05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
UNH UnitedHealth
$290.00 /

+0.7 (+0.24%)

TNDM TNDM
/

+

MDT Medtronic
$90.60 /

+0.38 (+0.42%)

UNH UnitedHealth
$290.00 /

+0.7 (+0.24%)

MDT Medtronic
$90.60 /

+0.38 (+0.42%)

UNH UnitedHealth
$290.00 /

+0.7 (+0.24%)

TNDM TNDM
/

+

MDT Medtronic
$90.60 /

+0.38 (+0.42%)

UNH UnitedHealth
$290.00 /

+0.7 (+0.24%)

MDT Medtronic
$90.60 /

+0.38 (+0.42%)

Monday
Hot Stocks
Abbott, Tandem Diabetes to develop integrated diabetes solutions » 09:20
06/29/20
06/29
09:20
06/29/20
09:20
TNDM

TNDM

/

+

, ABT

Abbott

$88.67 /

-0.945 (-1.05%)

Abbott (ABT) and Tandem…

Abbott (ABT) and Tandem Diabetes (TNDM) announced that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's continuous glucose monitoring, or CGM, technology with Tandem's insulin delivery systems to provide more options for people to manage their diabetes. The companies first announced their intention to work together in October 2019, and this resulting agreement covers the technical development of device integration and associated commercial support activities. The companies will partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options for diabetes management.

ShowHide Related Items >><<
TNDM TNDM
/

+

ABT Abbott
$88.67 /

-0.945 (-1.05%)

TNDM TNDM
/

+

06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
06/18/20 Raymond James
Tandem Diabetes price target raised to $95 from $88 at Raymond James
06/18/20 Lake Street
Tandem Diabetes price target raised to $125 from $100 at Lake Street
06/17/20 Piper Sandler
Tandem Diabetes Q2 tracking better than expected, says Piper Sandler
ABT Abbott
$88.67 /

-0.945 (-1.05%)

06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
06/01/20
Fly Intel: Top five analyst downgrades
TNDM TNDM
/

+

ABT Abbott
$88.67 /

-0.945 (-1.05%)

ABT Abbott
$88.67 /

-0.945 (-1.05%)

TNDM TNDM
/

+

ABT Abbott
$88.67 /

-0.945 (-1.05%)

ABT Abbott
$88.67 /

-0.945 (-1.05%)

Over a week ago
Hot Stocks
Tandem Diabetes acquires Sugarmate mobile app, terms undisclosed » 09:09
06/24/20
06/24
09:09
06/24/20
09:09
TNDM

TNDM

/

+

Tandem Diabetes announced…

Tandem Diabetes announced its acquisition of Sugarmate, a mobile app for people with diabetes who use insulin. Sugarmate will become a wholly owned subsidiary of Tandem Diabetes Care, and will continue to be led by its founder, Josh Juster who has joined the company as VP, Sugarmate. Financial terms of the acquisition were not disclosed. The Sugarmate app is designed to help people with diabetes visualize diabetes therapy data. It allows users to log glucose data and health and nutrition information and can provide notifications and alerts to users, their family and their caregivers.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

06/22/20 Oppenheimer
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer
06/18/20 Raymond James
Tandem Diabetes price target raised to $95 from $88 at Raymond James
06/18/20 Lake Street
Tandem Diabetes price target raised to $125 from $100 at Lake Street
06/17/20 Piper Sandler
Tandem Diabetes Q2 tracking better than expected, says Piper Sandler
TNDM TNDM
/

+

TNDM TNDM
/

+

TNDM TNDM
/

+

Recommendations
Tandem Diabetes price target raised to $102 from $92 at Oppenheimer » 07:34
06/22/20
06/22
07:34
06/22/20
07:34
TNDM

TNDM

/

+

Oppenheimer analyst…

Oppenheimer analyst Steven Lichtman raised the firm's price target on Tandem Diabetes to $102 from $92 and keeps an Outperform rating on the shares. While Control-IQ's strong market acceptance has been a driver of Tandem shares, the analyst believes the software work underway at the company is underappreciated. The expected introduction of a remote bolus feature for Tandem's t:slim is a big differentiator, allowing patients to significantly reduce time interacting with their pump, he contends. Lichtman assumes 2020-end launch. The analyst sees a "solid" runway ahead for Control-IQ with no additional hybrid closed-loop systems expected to come to the U.S. this year.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

06/18/20 Raymond James
Tandem Diabetes price target raised to $95 from $88 at Raymond James
06/18/20 Lake Street
Tandem Diabetes price target raised to $125 from $100 at Lake Street
06/17/20 Piper Sandler
Tandem Diabetes Q2 tracking better than expected, says Piper Sandler
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
TNDM TNDM
/

+

TNDM TNDM
/

+

TNDM TNDM
/

+

Recommendations
Tandem Diabetes price target raised to $95 from $88 at Raymond James » 09:34
06/18/20
06/18
09:34
06/18/20
09:34
TNDM

TNDM

/

+

Raymond James analyst…

Raymond James analyst Jayson Bedford raised the firm's price target on Tandem Diabetes to $95 from $88 and keeps an Outperform rating on the shares following management's positive business update at the RJ Human Health Innovation Conference. Specifically, Bedford says business trends in Q2 have tracked better than expected, both domestically and internationally, which should drive upside to the Q2 revenue guidance of "at least" $85M.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

06/18/20 Lake Street
Tandem Diabetes price target raised to $125 from $100 at Lake Street
06/17/20 Piper Sandler
Tandem Diabetes Q2 tracking better than expected, says Piper Sandler
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/10/20 Piper Sandler
Tandem Diabetes the 'standout' in Piper endocrinologist survey
TNDM TNDM
/

+

TNDM TNDM
/

+

TNDM TNDM
/

+

Recommendations
Tandem Diabetes price target raised to $125 from $100 at Lake Street » 08:42
06/18/20
06/18
08:42
06/18/20
08:42
TNDM

TNDM

/

+

Lake Street analyst…

Lake Street analyst Brooks O'Neil raised the firm's price target on Tandem Diabetes to $125 from $100 after the company announced FDA clearance of an expanded pediatric indication for the t:slim X2 insulin pump with Control-IQ technology and after its CEO and CFO conducted a fireside chat at a virtual healthcare conference. Tandem's CFO said they now expect sales to exceed both the domestic and international guidance provided for the quarter, though no specific information about expected results was provided beyond noting that greater demand has been seen then they anticipated when they provided Q2 revenue guidance of "at least $85M." O'Neil, who believes the "overwhelming innovations" Tandem has brought and will continue to bring to improve the management of diabetes stand out, keeps a Buy rating on the shares.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

06/17/20 Piper Sandler
Tandem Diabetes Q2 tracking better than expected, says Piper Sandler
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/10/20 Piper Sandler
Tandem Diabetes the 'standout' in Piper endocrinologist survey
06/03/20 Citi
Tandem Diabetes price target raised to $94 from $81 at Citi
TNDM TNDM
/

+

TNDM TNDM
/

+

TNDM TNDM
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.